26th Annual Meeting of the German Drug Utilisation Research Group (GAA)
Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie
21.11. - 22.11.2019, Bonn/Bad Godesberg
Abstracts
Meeting Abstract
(19gaa01)
[Full Text]
Hormones and dementia – pharmacoepidemiological analyses of German health insurance data
Hoffmann J, Gomm W, Weckbecker K, Hänisch B[Full Text]
Meeting Abstract
(19gaa02)
[Full Text]
Updated pocket guide for diagnosis and management of chronic obstructive pulmonary disease (COPD) at the University Hospital Jena
Farker K, Hartmann M, Kroegel C[Full Text]
Meeting Abstract
(19gaa03)
[Full Text]
SSRI co-medication with NOAC or vitamin K antagonist does not increase hospitalization for bleeding events. A retrospective nation-wide cohort study in Austria 2010–2015
Klopprogge S, Mittlböck M, Reichardt B, Wolzt M[Full Text]
Meeting Abstract
(19gaa04)
[Full Text]
Does magnesium supplementation benefit pregnancy? The LIFE Child pregnancy cohort
Bremer SUJ, Neininger MP, Bertsche A, Kiess W, Bertsche T[Full Text]
Meeting Abstract
(19gaa05)
[Full Text]
Prescribing of metamizole and opioids in Germany on a regional level in 2010
Jobski K, Hoffmann F, Bantel C, Dörks M[Full Text]
Meeting Abstract
(19gaa06)
[Full Text]
Zwischen Erlösung und Verdammnis – Versprechen und aktuelle Realität von artificial intelligence in Versorgungsforschung und -praxis
Meyer I[Full Text]
Meeting Abstract
(19gaa07)
[Full Text]
ARMIN – Influence of structured medication management on pharmacy loyalty
Waldleben V, Fuchs A[Full Text]
Meeting Abstract
(19gaa08)
[Full Text]
Medication management by clinical pharmacists in the “DemStepCare” innovation fund project – a prospective cluster randomized intervention study in patients with dementia
Kockläuner M, Mildner C, Krämer I[Full Text]
Meeting Abstract
(19gaa09)
[Full Text]
Pharmacotherapy of psychiatric inpatients with adjustment disorder – current status and changes between 2000 and 2016
Greiner T, Haack B, Toto S, Bleich S, Grohmann R, Heinze M, Schneider M[Full Text]
Meeting Abstract
(19gaa10)
[Full Text]
Cross-sector postgraduate interprofessional workshops as a preventive tool to avoid risks of polypharmacy in the elderly – 1. Feasibility? 2. Resonance? ...and a revelation
Wolf U[Full Text]
Meeting Abstract
(19gaa11)
[Full Text]
Safe sailing on a preventive course in gerontopharmacology and polypharmacy requires the hoisting of important presetting superior sails
Wolf U[Full Text]
Meeting Abstract
(19gaa12)
[Full Text]
Iatrogenic burden and components of so-called presbydysphagia? Health care research in oropharygeal dysphagia in the elderly analysing associated and drug related risk factors
Wolf U, Walter G, Wienke A, Gregor S[Full Text]
Meeting Abstract
(19gaa13)
[Full Text]
The influence of intervention complexity on barriers and facilitators in the implementation of professional pharmacy services – a systematic review
Möcker R, Terstegen T, Haefeli WE, Seidling H[Full Text]
Meeting Abstract
(19gaa14)
[Full Text]
Prescribing practice of proton pump inhibitors in nursing home residents – results of a secondary data analysis
Wegener M, Berg A, Fleischer S, Meyer G, Wolf U[Full Text]
Meeting Abstract
(19gaa15)
[Full Text]
Practical demonstrations of insulin administration to evaluate the emergency management of paediatric patients with type I diabetes mellitus
Eisenhofer S, Neininger MP, Bertsche A, Kiess W, Kapellen TM, Bertsche T[Full Text]
Meeting Abstract
(19gaa16)
[Full Text]
PRISCUS 2.0 – An update and expansion of the first German list of potentially inappropriate medications
Mann NK, Mathes T, Sönnichsen A, Niepraschk-von Dollen K, Pieper D, Thürmann PA[Full Text]
Meeting Abstract
(19gaa17)
[Full Text]
Multimorbidity and polypharmacy for patients with mental and behavioural disorders in outpatient treatment
Schuster F, Emcke T, Ostermann T[Full Text]
Meeting Abstract
(19gaa18)
[Full Text]
Multimorbidity and polypharmacy for diabetes patients using regional secondary data of the Statutory Health Insurance
Schuster R, Heidbreder M, Emcke T, Schuster M[Full Text]
Meeting Abstract
(19gaa19)
[Full Text]
Vaccination of children – Primary immunization according to official recommendations of STIKO
Lappe V, Schubert I, Grandt D[Full Text]
Meeting Abstract
(19gaa20)
[Full Text]
Needs assessment for an interprofessional academic program for medication safety
Thevissen J, Böhmer A, Al Ghaddioui R, Olejniczak K, Dartsch D, Hänisch B, Laven A, Mahler C, Paeschke N, Seidling H, Weltermann B, Woltersdorf R, Jaehde U[Full Text]
Meeting Abstract
(19gaa21)
[Full Text]
Development of basic approaches to artificial intelligence in pharmacotherapy
Rose O, Netz M, Bücker M[Full Text]
Meeting Abstract
(19gaa22)
[Full Text]
Developing and finalising a deprescribing manual
Bencheva V, Mann NK, Schmiedl S, Abraham J, Altiner A, Icks A, Mortsiefer A, Wiese B, Wilm S, COFRAIL study group[Full Text]
Meeting Abstract
(19gaa23)
[Full Text]
Prescribers’ compliance with SmPC recommendations for dabigatran, rivaroxaban, and apixaban – a European comparative drug utilization study
Schmiedl S, Rottenkolber M, Ibanez L, Sabate M, Ballarin E, Vidal X, Leon-Munoz L, Huerta C, Martin Merino E, Montero D, Gasse C, Anderson M, Asgaer M, De Bruin M, Gerlach R, Tauscher M, Souverein P, van den Ham R, Klungel O, Gardarsdottir H[Full Text]
